LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

CITADEL ADVISORS LLC's Holding History (CIK: 0001423053)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 4,506,857 Value ($000) $2,351 Avg Close — Range —
Q4 2024
Shares 3,754,745 Value ($000) $2,315 Avg Close — Range —
Q3 2024
Shares 1,777 Value ($000) $2 Avg Close — Range —
Q2 2024
Shares 275,721 Value ($000) $400 Avg Close — Range —
Q1 2024
Shares 786,344 Value ($000) $1,754 Avg Close — Range —
Q4 2023
Shares 3,477,228 Value ($000) $6,746 Avg Close — Range —
Q3 2023
Shares 747,143 Value ($000) $1,098 Avg Close — Range —
Q2 2023
Shares 40,724 Value ($000) $130 Avg Close — Range —
Q1 2023
Shares 59,222 Value ($000) $140 Avg Close — Range —
Q4 2022
Shares 17,074 Value ($000) $59 Avg Close — Range —
Q1 2022
Shares 249,038 Value ($000) $1,258 Avg Close — Range —
Q4 2021
Shares 342,694 Value ($000) $2,652 Avg Close — Range —
Q3 2021
Shares 187,729 Value ($000) $2,778 Avg Close — Range —
Q2 2021
Shares 328,033 Value ($000) $5,327 Avg Close — Range —